NO20040962L - Anvendelse av hCG og LH ved kontrollert ovariehyperstimulering - Google Patents

Anvendelse av hCG og LH ved kontrollert ovariehyperstimulering

Info

Publication number
NO20040962L
NO20040962L NO20040962A NO20040962A NO20040962L NO 20040962 L NO20040962 L NO 20040962L NO 20040962 A NO20040962 A NO 20040962A NO 20040962 A NO20040962 A NO 20040962A NO 20040962 L NO20040962 L NO 20040962L
Authority
NO
Norway
Prior art keywords
hcg
ovarian hyperstimulation
controlled ovarian
controlled
hyperstimulation
Prior art date
Application number
NO20040962A
Other languages
English (en)
Other versions
NO327153B1 (no
Inventor
Yves Menezo
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8182262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040962(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20040962L publication Critical patent/NO20040962L/no
Publication of NO327153B1 publication Critical patent/NO327153B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20040962A 2001-09-12 2004-03-05 Anvendelse av hCG og hLH i fremstilling av legemidler NO327153B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01307758 2001-09-12
PCT/GB2002/004167 WO2003022303A2 (en) 2001-09-12 2002-09-12 Use of hcg and lh in controlled ovarian hyperstimulation

Publications (2)

Publication Number Publication Date
NO20040962L true NO20040962L (no) 2004-03-05
NO327153B1 NO327153B1 (no) 2009-05-04

Family

ID=8182262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040962A NO327153B1 (no) 2001-09-12 2004-03-05 Anvendelse av hCG og hLH i fremstilling av legemidler

Country Status (27)

Country Link
US (1) US7402558B2 (no)
EP (1) EP1425033B1 (no)
JP (1) JP2005501919A (no)
KR (1) KR20040032952A (no)
CN (1) CN100376289C (no)
AR (1) AR036593A1 (no)
AT (1) ATE489964T1 (no)
BR (1) BR0212447A (no)
CA (1) CA2457851A1 (no)
CY (1) CY1110991T1 (no)
DE (1) DE60238490D1 (no)
DK (1) DK1425033T3 (no)
EA (1) EA009279B1 (no)
ES (1) ES2356895T3 (no)
HK (1) HK1067865A1 (no)
HR (1) HRP20040086A2 (no)
IL (1) IL160782A0 (no)
ME (1) MEP38708A (no)
MX (1) MXPA04002257A (no)
NO (1) NO327153B1 (no)
PL (1) PL369021A1 (no)
PT (1) PT1425033E (no)
SI (1) SI1425033T1 (no)
UA (1) UA82052C2 (no)
WO (1) WO2003022303A2 (no)
YU (1) YU21104A (no)
ZA (1) ZA200400781B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040248784A1 (en) * 2003-06-03 2004-12-09 Marco Filicori Unitary combinations of FSH and hCG
GB0723882D0 (en) * 2007-12-07 2008-01-23 Univ Leicester Methods for the detection of a threatened miscarriage
AU2012286048A1 (en) 2011-07-18 2014-02-20 Arts Biologics A/S Long acting luteinizing hormone (LH) compound
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
ES2716862T3 (es) * 2014-12-22 2019-06-17 Ferring Bv Terapia con antagonistas del receptor de oxitocina en la fase lútea para la implantación y embarazo en mujeres que se someten a tecnologías de reproducción asistida
FI3261661T3 (fi) 2015-02-26 2024-01-15 Ferring Bv Menotropiini hedelmättömyyden hoitamiseksi
US11185569B2 (en) * 2016-05-04 2021-11-30 University Of Cincinnati ActRIIB:Fc to treat infertility in females
TWI846743B (zh) * 2018-10-17 2024-07-01 荷蘭商菲林公司 用於控制性卵巢刺激之組成物及方法
CN110041436A (zh) * 2019-04-28 2019-07-23 广州威生医药科技有限公司 长效重组fsh融合蛋白在母猪批次化生产中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4589402A (en) 1984-07-26 1986-05-20 Serono Laboratories, Inc. Method of in vitro fertilization
US5705478A (en) * 1989-02-21 1998-01-06 Washington University Covalently linked β subunits of the glycoprotein hormones as antagonists
FR2744367B1 (fr) * 1996-02-02 1999-07-09 Emperaire Jean Claude Medicaments pour le declenchement de l'ovulation
WO1998058657A1 (en) * 1997-06-20 1998-12-30 Akzo Nobel N.V. Gonadotropin releasing hormone antagonist
ZA987497B (en) * 1997-09-08 1999-02-23 Akzo Nobel Nv Expression of gonadotropins in dictyostelium
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
KR20010093280A (ko) * 1999-02-24 2001-10-27 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 불임증 치료
SI1176976T2 (sl) * 1999-05-07 2015-12-31 Merck Serono Sa Uporaba LH, dajanega v srednji ali pozni folikularni fazi, za zdravljenje anovulatornih žensk
PL211113B1 (pl) * 2000-01-27 2012-04-30 Serono Lab Zastosowanie FSH do leczenia bezpłodności
US6953774B2 (en) * 2000-08-11 2005-10-11 Applied Research Systems Ars Holding N.V. Methods of inducing ovulation

Also Published As

Publication number Publication date
MXPA04002257A (es) 2004-07-23
CY1110991T1 (el) 2015-06-11
MEP38708A (en) 2011-02-10
YU21104A (sh) 2006-08-17
JP2005501919A (ja) 2005-01-20
US7402558B2 (en) 2008-07-22
DK1425033T3 (da) 2011-01-10
CN1553810A (zh) 2004-12-08
WO2003022303A3 (en) 2003-12-18
HRP20040086A2 (en) 2004-12-31
NO327153B1 (no) 2009-05-04
PT1425033E (pt) 2010-12-29
CA2457851A1 (en) 2003-03-20
SI1425033T1 (sl) 2011-01-31
ES2356895T3 (es) 2011-04-14
WO2003022303A2 (en) 2003-03-20
DE60238490D1 (de) 2011-01-13
CN100376289C (zh) 2008-03-26
BR0212447A (pt) 2004-08-17
AR036593A1 (es) 2004-09-22
HK1067865A1 (en) 2005-04-22
EA200400426A1 (ru) 2004-08-26
ZA200400781B (en) 2005-04-26
EP1425033B1 (en) 2010-12-01
ATE489964T1 (de) 2010-12-15
EP1425033A2 (en) 2004-06-09
EA009279B1 (ru) 2007-12-28
PL369021A1 (en) 2005-04-18
UA82052C2 (uk) 2008-03-11
US20050020489A1 (en) 2005-01-27
IL160782A0 (en) 2004-08-31
KR20040032952A (ko) 2004-04-17

Similar Documents

Publication Publication Date Title
HK1067867A1 (en) Use of hcg in controlled ovarian hyperstimulation
FI20001369A (fi) Ranteessa pidettävä elektroninen laite ja sen ohjausmenetelmä
HK1062457A1 (en) Modified and stabilized gdf propeptides and uses thereof
DE60142740D1 (de) Steuerbares und flügelstabilisiertes geschoss
NO20035379D0 (no) Fremgangsmåte og anordning for degree kning av hårvolum
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
DE60215046D1 (de) Vernebler und anwendungsverfahren
DK1527067T3 (da) 4-Trifluormethylpyrazolylsubstituerede pyridiner og pyrimidiner
EP1425162A4 (en) OPTICAL MATERIALS AND OPTICAL DEVICES
DE60238206D1 (de) Frequenz- und amplitudenapodisierung von wandlern
PL369855A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
HK1067866A1 (en) Use of lh in controlled ovarian hyperstimulation
NO20033469L (no) Elektrodebelegg og dets anvendelse ved fremstillingen av klorat
IL160379A0 (en) Lens of gradient dielectric constant and methods of production
NO20040962L (no) Anvendelse av hCG og LH ved kontrollert ovariehyperstimulering
EP1425580A4 (en) LYMPHATIC ENDOTHELIAL CELLS AND METHODS THEREOF
GB0327818D0 (en) Personal story and event organiser
DE60204749D1 (de) Abtast- und Halteschaltung
EP1447737A4 (en) INPUT DEVICE AND METHOD FOR THEIR MANUFACTURE
NO20031272L (no) Fremgangsmåte og form for kald isopressing
DK1390516T3 (da) Hidtil ukendte ekspressionsvektorer og anvendelser deraf
DE60214586T8 (de) Pulverbeschichtungsvorrichtung und -verfahren
NO20010803D0 (no) Fremgangsmåte ved alkylering og nye hydroksyfenylbenztriazoler
AU2002306045A8 (en) Ferroelectric devices and method relating thereto
DE60113300D1 (de) Piperazinylcarbonylchinoline und isochinoline

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS

MM1K Lapsed by not paying the annual fees